A randomized trial of the North West Oncology Group (GONO) comparing intraperitoneal (ip) versus intravenous (iv) cisplatin (CDDP) in combimation with epidoxorubicin (epidox) and cyclophosphamide (CTX) in advanced ovarian carcinoma patients with residual disease <2cm after initial laparotomy